Usefulness of lymphocyte activation test in atorvastatin hypersensitivity
Piñero Saavedra, M.C.; Prados Castaño, M.; Sánchez, B.; Lucena Soto, J.M.; Avila Castellanos, R.; Ortega-Camarero, M.
Journal of Investigational Allergology and Clinical Immunology 21(7): 574-575
2011
ISSN/ISBN: 1018-9068 PMID: 22312946 Document Number: 655254
Document emailed within 1 workday
Related Documents
Gaga, M.; Frew, A.J.; Varney, V.A.; Kay, A.B. 1991: Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity Journal of Immunology 147(3): 816-822Cabrera-Freitag, P.; Ferrer, M.; Martínez, R.; Javaloyes, G.; Sanz, M.L. 2011: The basophil activation test as a promising diagnostic tool in hypersensitivity to chironomid larvae Journal of Investigational Allergology and Clinical Immunology 21(2): 158-159
Del Rey Calero, J.; Calbo Torrecillas, F. 1970: Some immunologic aspects of psoriasis. Study of cellular hypersensitivity, using the lymphocyte migration inhibition test (MIT) Revista de Sanidad E Higiene Publica 44(12): 1333-1347
Lazarovits, A.I.; Moscicki, R.A.; Kurnick, J.T.; Camerini, D.; Bhan, A.K.; Baird, L.G.; Erikson, M.; Colvin, R.B. 1984: Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen Journal of Immunology 133(4): 1857-1862
Kelly, R.H.; Wolstencroft, R.A.; Dumonde, D.C.; Balfour, B.M. 1972: Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation Clinical and Experimental Immunology 10(1): 49-65
Hughes, D.; Paty, D.W. 1972: Macrophage migration inhibition test applied to delayed hypersensitivity in man. I. a mixed lymphocyte reaction between human and guinea-pig lymphocytes demonstrated using a sensitive micro-capillary method Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 142(5): 478-487
Itoh, Y.; Kin, K.; Takagi, K.; Kawai, T.; Kasahara, T. 1979: Activation of normal adult peripheral B cell by Staphylococcus aureus Cowan I strain organisms and its clinical usefulness as a B cell function test Rinsho Byori. Japanese Journal of Clinical Pathology 27(12): 1091-1094
Schmid, D.S.; Rouse, B.T. 1983: Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors Journal of Immunology 131(1): 479-484
DifeliceAntonio, R.; Sarti, G.; Savorani, G. 1976: Cellular immunity in the aged as evaluated by a delayed hypersensitivity test in vivo (intradermal test and contact test) Bollettino della Societa Italiana di Biologia Sperimentale 52(12): 866-871
Chansrichavala, P.; Chantharaksri, U.; Sritara, P.; Chaiyaroj, S.C. 2009: Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway Asian Pacific Journal of Allergy and Immunology 27(1): 49-57
Ashman, R.F. 1990: B lymphocyte activation: the transferrin receptor as a prototype intermediate activation molecule Journal of Laboratory and Clinical Medicine 116(6): 759-765
Santanu, G.; Suhrita, P.; Mookerjee, S.; Tania, K.; Mita, S.; Pramit, G.; Sharmila, G.; Miraj, M.; Debdutta, M. 2011: Lipid modifying action of atorvastatin in comparison to combination of atorvastatin and nicotinic acid in patients with ischaemic heart disease Indian Heart Journal 63(5): 434-437
Fischman, C.M.; Udey, M.C.; Kurtz, M.; Wedner, H.J. 1981: Inhibition of lectin-induced lymphocyte activation by 2-cyclohexene-1-one: decreased intracellular glutathione inhibits an early event in the activation sequence Journal of Immunology 127(6): 2257-2262
Wagner, M.; Goetghebeur, M.; Merikle, E.; Pandya, A.; Chu, P.; Taylor, D.C.A. 2009: Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada Canadian Journal of Clinical Pharmacology 16(2): E331-E345
Gundersen, D.; Trân-Thang, C.; Sordat, B.; Mourali, F.; Rüegg, C. 1997: Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering Journal of Immunology 158(3): 1051-1060
Ten Napel, C.H.; The, T.H.; Bijker, J.; De Gast, G.C.; Langenhuysen, M.M. 1977: Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test Clinical and Experimental Immunology 29(1): 52-60
Sone, S.; Sano, T.; Ohguchi, H.; Yata, K.; Tsubura, E. 1977: Phytohemagglutinin skin test in cancer patients: correlation with in vitro lymphocyte blastogenesis to mitogens and total E-rosette forming lymphocyte count Tokushima Journal of Experimental Medicine 24(3-4): 75-80
Cabarcos Ortiz de Barrón, A.; Lado Lado, F.L.; Pestoni Porvén, C.; Lorenzo Zúñiga, V. 2001: Usefulness of skin tests (tuberculin and delayed-type hypersensitivity reaction) in patients with HIV infection Anales de Medicina Interna 18(12): 644-649
Brarda, O.A.; Vanella, L.M.; Greco, C.R. 1989: Lymphocyte blastogenesis in children with cow's milk hypersensitivity after its elimination from the diet Allergologia et Immunopathologia 17(1): 45-48
Issekutz, T.B.; Stoltz, J.M.; vd Meide, P. 1988: Lymphocyte recruitment in delayed-type hypersensitivity. the role of IFN-gamma Journal of Immunology 140(9): 2989-2993